Article
Nadolol block of Nav1.5 does not explain its efficacy in the long QT syndrome.
Journal of cardiovascular pharmacology - 1 Mar 2012
Besana Alessandra, Wang Dao W, George Alfred L, Schwartz Peter J
Abstract excerpt
Beta-adrenergic receptor antagonists (β-blockers) are the therapy of choice for the long QT syndrome but their efficacy is not homogeneous: propranolol and nadolol are the most effective, whereas metoprolol is associated with more treatment failures. Propranolol has a blocking effect on the sodium current ("membrane-stabilizing" effect), and it has been hypothesized that the efficacy of nadolol might be due to a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
